Remove Genetic Engineering Remove Immune Response Remove Medicine
article thumbnail

In the precision medicine era, the line between products and services is blurred

pharmaphorum

Personalized and precision medicines are exciting fields that focus on the development of treatment and prevention strategies for a single patient or patient group. Personalized and precision medicine, however, can offer specialized treatments that target the patient’s unique cancer subtype, its genetic mutations, and the affected tissues.

article thumbnail

South African variant may cut response from Pfizer/BioNTech shot, study finds

pharmaphorum

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The New Frontier in Drug Development: Understanding Biologics and Small Molecules

Cloudbyz

In the intricate dance of drug discovery and development, two protagonists emerge as the cornerstones of modern medicine: biologics and small molecules. They are often used to mimic or enhance natural biological processes, such as immune responses. Their small size allows them to distribute widely throughout the body.

article thumbnail

Pfizer/BioNTech COVID jab works against Brazil variant; lab study

pharmaphorum

The study suggests that serum taken from patients injected with the mRNA shot, also known as BNT162b2, was able to neutralise a genetically engineered version of SARS-CoV-2 with the P.1 The latest research is published in the New England Journal of Medicine. 1 – that is worrying health officials around the world. .

Vaccine 66
article thumbnail

Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 VaccineAdvance purchase agreement signed for NVX-CoV2373, Novavax’ adjuvanted protein vaccine candidate

The Pharma Data

Currently in Phase 3 clinical testing in the United Kingdom for the prevention of COVID-19, NVX-CoV2373 is a recombinant protein vaccine adjuvanted with Novavax’ proprietary Matrix-M to enhance the immune response. Additional terms of the agreement were not disclosed. About NVX-CoV2373. About Novavax. Novavax, Inc.?(Nasdaq:

Protein 52
article thumbnail

mRNA Cancer Vaccines and Therapies: An Overview

Advarra

Immunotherapy and Personalized Medicine Incorporating immunotherapy is becoming increasingly popular in oncology research, creating opportunities for cancer treatments to leverage the body’s own immune system. Adoptive T Cell Therapies Adoptive T cell therapy is another form of cancer treatment leveraging the patient’s immune system.

article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

Treatment vaccines : these boost the immune system responses to target cells. Immune system modulators (i.e. receptors) of the immune system to enhance, or suppress immune responses. Suri, as the company’s approach is “a very unique marriage between very rational protein engineering and immunology.”.

Protein 98